trefoiltherapeutics.net

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.trefoiltherapeutics.net/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Trefoil
Description	Trefoil Therapeutics corporate
Keywords	Corneal dystrophies, FGF-1, Fuchs’ Dystrophy, Ophthalmology

Server Information

WebSite	trefoiltherapeutics.net
Host IP	185.230.63.171
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

trefoiltherapeutics.net Valuation

US$321,432

Last updated: 2023-05-18 17:29:43

trefoiltherapeutics.net has Semrush global rank of 32,928,604. trefoiltherapeutics.net has an estimated worth of US$ 321,432, based on its estimated Ads revenue. trefoiltherapeutics.net receives approximately 37,089 unique visitors each day. Its web server is located in -, with IP address 185.230.63.171. According to SiteAdvisor, trefoiltherapeutics.net is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$321,432
Daily Ads Revenue	US$297
Monthly Ads Revenue	US$8,902
Yearly Ads Revenue	US$106,815
Daily Unique Visitors	2,473
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
trefoiltherapeutics.net. 3600	A	trefoiltherapeutics.net. 3600	IP: 185.230.63.171
trefoiltherapeutics.net. 3600	A	trefoiltherapeutics.net. 3600	IP: 185.230.63.107
trefoiltherapeutics.net. 3600	A	trefoiltherapeutics.net. 3600	IP: 185.230.63.186
trefoiltherapeutics.net. 86400	NS	trefoiltherapeutics.net. 86400	NS Record: ns15.wixdns.net.
trefoiltherapeutics.net. 86400	NS	trefoiltherapeutics.net. 86400	NS Record: ns14.wixdns.net.

HtmlToTextCheckTime:2023-05-18 17:29:43

top of page HOME Vision and Mission Management Team Board of Directors Investors Advisors Trefoil Therapeutics History PIPELINE Cornea Anatomy Dystrophies Publications Press Releases Events CONTACT Trefoil is a biotechnology company focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop first-in-class regenerative pharmacologic treatments for corneal diseases, which are debilitating and cause a significant amount of preventable blindness throughout the world. Lead candidate TTHX1114 is an engineered form of FGF-1 designed to stimulate proliferation and migration of corneal endothelial cells. It is initially being developed as an intracameral injection as the first pharmacologic treatment for back of the cornea surface disease (endothelial dystrophy), the leading cause of cornea transplantation surgeries. Trefoil’s second development program focuses on a topical eye drop formulation of TTHX1114 for the treatment of ulcerative

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Fri, 08 Jul 2022 08:55:43 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.trefoiltherapeutics.net/
strict-transport-security: max-age=3600
x-wix-request-id: 1657270543.3461434166233526551
Age: 0
Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=84
X-Seen-By: qdrMdw4zrP0/E6B8JtgqKA==,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVj+FjnM9a0TCoelsAvbB53h,m0j2EEknGIVUW/liY8BLLpKOvBhYRuLEqdCLHFrW+6fQYjEJxCMSl2Cb+N3EkeV+,2d58ifebGbosy5xc+FRalml/I44ZCgWNeZt/yQTivxuBQgDWL/c8YiR44uOvvCMm22mQT1VI7inJV6ora5i+2Q==,2UNV7KOq4oGjA5+PKsX47L/w64C2MEzM6m+Hxfbfe91YgeUJqUXtid+86vZww+nL,7npGRUZHWOtWoP0Si3wDp2+3SnxHb8m1PBw/J2Wvl+4=,xTu8fpDe3EKPsMR1jrheELdtkir9Eg1CjzTdj/oPJ98=,kO0u+7q+TL0DeeE//9W7MEszwTckH0JHjpfuN1T8CwarvnV1F5l2WKT/aUiUX/hIWIHlCalF7YnfvOr2cMPpyw==
Cache-Control: no-cache
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Fri, 08 Jul 2022 08:55:43 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1657270543.5785977178038360
content-language: en
strict-transport-security: max-age=3600
age: 0
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMckSlNE7V6/8VtrARMclgnA,qquldgcFrj2n046g4RNSVFU+wIjSmTlxqMUV00MvxJE=,2d58ifebGbosy5xc+FRall/BT+NifGO3YetC6NTHXDH5hJ+AIHOlJZwSgLODgocB3QpI/ucnHvfrUjeESIoVegDh8aIKFtQOze0aX93Kwoo=,2UNV7KOq4oGjA5+PKsX47HCc7DfwHPKx9/67HjQqEMOa46R9xNIlpQ4eUPYpBuqs,7npGRUZHWOtWoP0Si3wDpyFZbvZqqFRGVQQXLMgdg6E=,kO0u+7q+TL0DeeE//9W7MNvn6NomFbOnz4A6kr3Cu5h83pIg6jRfSqqGm6qsjtssgavG7/btK3d2+RPXdqSxwg==,xTu8fpDe3EKPsMR1jrheEG7q83kCWA5iASSgrXlKrhI=,LoUK8/saGAmOxZWtpubo2hcwhzQ19MpqtihQk1Btn7p9lzlZOtOQG+fcu5Cb/qwtkpzEzEtENMzNE04JVDeN8A==,xTu8fpDe3EKPsMR1jrheEFGhBbk9x46BrlDWm/97oF0=,xTu8fpDe3EKPsMR1jrheEKSgjluVbGx7ZwhjlSdp81Q=,/a5ccLSK1HEmwPNg/x6Ouoy2twHrxW2YoXkeZoj/kf0sSyx4/9Sw8C7XqLIbXqkaXmD06yVCAB3qWTl08iO1lg==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=eun1_g; Max-Age=20; Expires=Fri, 08 Jul 2022 08:56:03 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=eun1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

trefoiltherapeutics.net Whois Information

Domain Name: TREFOILTHERAPEUTICS.NET
Registry Domain ID: 1911927398_DOMAIN_NET-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2020-02-20T15:06:35Z
Creation Date: 2015-03-21T15:05:01Z
Registry Expiry Date: 2023-03-21T15:05:01Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS14.WIXDNS.NET
Name Server: NS15.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-07-08T09:03:50Z <<<

trefoiltherapeutics.net valuation and analysis